PROVIREX

Welcome to the Brand page for “PROVIREX”, which is offered here for Medical and veterinary preparations and articles, medications and natural remedies in the nature of anti-viral medications; antiviral drugs for treating hiv; biological and biotechnological preparations for medical and veterinary purposes, in particular for treating hiv;chemical substances for anti-viral use, chemical raw materials and chemical preparations in the form of powders, liquids or pastes; chemicals in the nature of anti-viral agents for use in the pharmaceutical industry; chemical compositions for use in science; biological preparations for use in industry and science; chemicals for industrial and scientific biotechnological purposes;healthcare for human beings and animals, in particular for treating hiv; medical services featuring gene therapy; pharmaceutical compounding services; healthcare services, clinical, medical, pharmaceutical and veterinary consultancy;scientific and technological services, scientific research in the field of virology; biological, biotechnological, clinical, medical and veterinary, pharmaceutical research and development; research in the field of gene therapy;.

Its status is currently believed to be active. Its class is unavailable. “PROVIREX” is believed to be currently owned by “PROVIREX Genome Editing Therapies GmbH”.